GP Approach to COPD Diagnosis and Management
For any smoker aged 40+ with chronic breathlessness, cough, or sputum production, confirm COPD diagnosis with post-bronchodilator spirometry showing FEV1/FVC <0.70, then immediately prioritize smoking cessation and initiate bronchodilator therapy based on symptom severity and exacerbation risk 1, 2.
DIAGNOSIS
Who to Test
- All smokers aged 40+ with respiratory symptoms 3
- Symptoms to screen for:
- Chronic breathlessness (at rest or with exertion)
- Chronic cough (with or without sputum)
- History of wheezing
- Recurrent lower respiratory infections
Diagnostic Confirmation
Spirometry is mandatory - clinical suspicion alone is insufficient 2, 1
- Diagnostic criterion: Post-bronchodilator FEV1/FVC <0.70 2, 1
- Measure FEV1 to grade severity of airflow obstruction 2
- Key clinical predictors that increase likelihood:
- Smoking history >40 pack-years
- Age >45 years
- Peak flow <350 L/min
- Diminished breath sounds 4
Caveat: Fixed ratio may over-diagnose in elderly or under-diagnose in young patients 2
STABLE COPD MANAGEMENT
1. Smoking Cessation (HIGHEST PRIORITY)
This is the ONLY intervention proven to slow disease progression 3, 5
- Offer pharmacotherapy: varenicline, bupropion, or nortriptyline 5
- Add nicotine replacement therapy 3, 5
- Long-term quit rates up to 25% achievable with dedicated resources 5
2. Pharmacotherapy Algorithm
Asymptomatic patients (FEV1 60-80%): No routine bronchodilators needed 1
Symptomatic patients with FEV1 60-80%: May use inhaled bronchodilators 1
Symptomatic patients with FEV1 <60%:
- Start with long-acting bronchodilator monotherapy (either LAMA or LABA) 1
- Choose based on cost, patient preference, and side effect profile 1
- If inadequate symptom control: Add second long-acting bronchodilator or inhaled corticosteroid 1
Always verify inhaler technique at every visit 3, 5
3. Non-Pharmacological Interventions
Vaccinations (reduce mortality/morbidity):
Pulmonary Rehabilitation:
- Mandatory for FEV1 <50% with symptoms 1
- Consider for FEV1 >50% if symptomatic or exercise-limited 1
- Improves exercise performance, reduces breathlessness, enhances quality of life 3, 5
Lifestyle Management:
Long-Term Oxygen Therapy (LTOT):
- Only if PaO2 ≤55 mmHg (7.3 kPa) or SpO2 ≤88% - this prolongs life 3, 1, 5
- Requires objective blood gas measurement 3
- Do NOT prescribe routinely for moderate desaturation 5
ACUTE EXACERBATION MANAGEMENT (HOME TREATMENT)
Treatment Criteria
Increase or add bronchodilators - verify inhaler technique 3
Prescribe antibiotics if ≥2 of the following:
- Increased breathlessness
- Increased sputum volume
- Purulent sputum 3
Oral corticosteroids: May be used in select cases 3
Follow-Up
- If no improvement in 2 weeks: Order chest X-ray and refer to specialist 3
- Reassess at 4-6 weeks: Check FEV1, inhaler technique, lifestyle factors 3
WHEN TO REFER TO SPECIALIST
Immediate/urgent referral 3:
- Suspected severe COPD (confirm diagnosis, optimize treatment)
- Onset of cor pulmonale
- COPD in patient <40 years (screen for α1-antitrypsin deficiency)
- Uncertain diagnosis
- Rapid decline in FEV1
- Frequent infections (exclude bronchiectasis)
- Symptoms disproportionate to lung function
- Assessment for oxygen therapy (requires blood gas measurement)
- Assessment for long-term oral corticosteroids
- Bullous disease (surgical evaluation)
COMMON PITFALLS
- Diagnosing COPD without spirometry - symptoms alone are insufficient 2, 1
- Prescribing inhaled therapy to symptomatic smokers without confirmed airflow obstruction 2
- Failing to verify inhaler technique at every visit 3, 5
- Prescribing oxygen without objective hypoxemia documentation 3
- Not prioritizing smoking cessation - this is the only disease-modifying intervention 3, 5
- Attributing symptoms to COPD when comorbidities (heart failure, deconditioning) may be responsible 1